Manfredini R, Finzi A, Bertoni T, Lamarchesina U, Nador F, Lotto A
Divisione di Cardiologia, Ospedale Maggiore IRCCS, Milano.
G Ital Cardiol. 1994 Nov;24(11):1379-86.
Echo-dipyridamole test is an useful tool for non-invasive demonstration of inducible myocardial ischemia in patients with coronary artery disease, its sensitivity being consistently higher as compared with classic exercise stress testing. However, in patients with single vessel who often perform a normal or borderline stress test, even the sensibility of echo-dipyridamole test is comparatively reduced.
In 19 patients with clinically suspected angina (effort-related in 4, at rest in 8, mixed in 7) and normal exercise stress test, standard echo-dipyridamole test was performed. Thereafter, rapid atrial pacing, a procedure associated with a sharp increase of myocardial oxygen consumption, was performed by means of a transoesophageal catheter during the proceeding 5 min and during 4 min of repeated dipyridamole 0.56 mg/kg infusion.
Standard echo-dipyridamole test induced ventricular wall motion abnormalities in 3 patients (one with borderline exercise stress test), whereas repeated pacing-sensitized procedure obtained wall motion abnormalities (apical, septal and lateral) in the same and in 4 additional patients. Coronary angiography demonstrated > 70% stenosis in 8/19 patients (single vessel disease in 5), 7 of whom had been correctly recognized by pacing-dipyridamole test; therefore, sensitivity of the latter as compared with standard dipyridamole test was 87% and 37% respectively. The anatomic correlation of induced wall motion abnormalities with coronary arterial stenosis was demonstrated in all cases. Specificity was 100% with both methods.
Although limited by its restricted patient population, this study suggests that atrial pacing, performed via transoesophageal catheter, can significantly improve the positive predictive value of echo-dipyridamole test in coronary artery disease. By means of this simple procedure, the possibility of non invasively diagnosing even single vessel stenosis in patients with inconclusive exercise stress testing can be significantly improved.
双嘧达莫负荷试验是用于无创性显示冠心病患者诱发心肌缺血的一种有用工具,与传统运动负荷试验相比,其敏感性一直较高。然而,在单支血管病变的患者中,这些患者的运动负荷试验结果常为正常或临界值,即便双嘧达莫负荷试验的敏感性也相对降低。
对19例临床疑似心绞痛患者(4例与劳力相关,8例静息时发作,7例混合性发作)且运动负荷试验正常者进行标准双嘧达莫负荷试验。此后,在接下来的5分钟内通过经食管导管进行快速心房起搏,这一操作会使心肌耗氧量急剧增加,同时在重复静脉输注双嘧达莫0.56mg/kg的4分钟内也进行快速心房起搏。
标准双嘧达莫负荷试验使3例患者(1例运动负荷试验为临界值)出现室壁运动异常,而重复起搏激发试验使同样的3例患者以及另外4例患者出现壁运动异常(心尖、室间隔和侧壁)。冠状动脉造影显示19例患者中有8例(5例为单支血管病变)存在>70%的狭窄,其中7例通过起搏-双嘧达莫试验被正确识别;因此,后者相对于标准双嘧达莫试验的敏感性分别为87%和37%。在所有病例中均证实了诱发的壁运动异常与冠状动脉狭窄之间的解剖学相关性。两种方法的特异性均为100%。
尽管本研究受限于患者数量有限,但提示经食管导管进行心房起搏可显著提高双嘧达莫负荷试验对冠心病的阳性预测价值。通过这一简单操作,对于运动负荷试验结果不确定的患者,无创诊断单支血管狭窄的可能性可显著提高。